Sodelglitazar

C23H21F4NO3S2

Sodelglitazar, 447406-78-2, Sodelglitazar [USAN:INN], UNII-6G973E04VI, GW677954, Sodelglitazar [USAN], 6G973E04VI, 2-(4-(((2-(2-Fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)-2-methylpropanoic acid, Sodelglitazar (USAN), GW 677954, GW-677954, 2-[4-[[[2-[2-Fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methyl]sulfanyl]-2-methylphenoxy]-2-methylpropanoic acid, Propanoic acid, 2-(4-(((2-(2-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-5-thiazolyl)methyl)thio)-2-methylphenoxy)-2-methyl-, SODELGLITAZAR [INN], SCHEMBL4822839, CHEMBL2104984, DTXSID90196289, 2-[4-[[2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]-2-methylpropanoic acid, DB-070588, FT-0743554, D06647, Q15708299, 2-{4-[({2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy-}-2-methylpropanoic acid, 2-{4-[({2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methyl)thio]-2-methylphenoxy}-2-methylpropanoic acid

Sodelglitazar is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate